Active Ingredient History
Dehydroepiandrosterone (DHEA), also known as androstenolone, is an endogenous steroid hormone precursor. It is one of the most abundant circulating steroids in humans. DHEA is produced in the adrenal glands, the gonads, and the brain. It functions as a metabolic intermediate in the biosynthesis of the androgen and estrogen sex steroids both in the gonads and in various other tissues. However, DHEA also has a variety of potential biological effects in its own right, binding to an array of nuclear and cell surface receptors, and acting as a neurosteroid and modulator of neurotrophic factor receptors. Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Addison Disease (Phase 3)
Adrenal Insufficiency (Phase 3)
Aging (Phase 3)
Androgens (Phase 2)
Anorexia Nervosa (Phase 2/Phase 3)
Back Pain (Phase 2)
Blood Coagulation (Phase 2)
Breast Neoplasms (Phase 4)
Burns (Phase 2/Phase 3)
Contraception Behavior (Phase 2)
Crohn Disease (Phase 2)
Cumulus Cells (Phase 3)
Dehydroepiandrosterone (Phase 3)
Depressive Disorder (Phase 2)
Dermatology (Phase 1)
Diabetes Mellitus, Type 1 (Early Phase 1)
Drugs, Investigational (Phase 3)
Erectile Dysfunction (Phase 2)
Frailty (Phase 4)
Healthy Volunteers (Phase 3)
HIV Infections (Phase 2)
Hormones (Phase 1)
Hot Flashes (Phase 2/Phase 3)
Hypertension, Pulmonary (Phase 3)
Immunosenescence (Phase 2)
Infertility (Phase 4)
Infertility, Female (Phase 2/Phase 3)
Lacrimal Apparatus Diseases (Phase 2)
Libido (Phase 3)
Lupus Erythematosus, Systemic (Phase 3)
Malaria (Phase 3)
Menopause (Phase 4)
Menstruation Disturbances (Phase 1)
Metabolic Side Effects of Drugs and Substances (Early Phase 1)
Mood Disorders (Phase 2)
Myotonic Dystrophy (Phase 2/Phase 3)
Orgasm (Phase 2/Phase 3)
Osteoporosis (Phase 4)
Ovarian Diseases (Phase 3)
Ovulation (Phase 2/Phase 3)
Pharmacokinetics (Phase 1)
Postmenopause (Phase 2)
Predictive Value of Tests (Phase 3)
Primary Ovarian Insufficiency (Phase 1/Phase 2)
Pulmonary Arterial Hypertension (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Quality of Life (Phase 3)
Reproductive Health (Phase 3)
Salivary Gland Diseases (Phase 2)
Sarcoma, Synovial (Phase 1/Phase 2)
Sjogren's Syndrome (Phase 4)
Skin Aging (Phase 3)
Stress Disorders, Post-Traumatic (Phase 2)
Survivors (Phase 2)
Urinary Incontinence (Phase 2/Phase 3)
Vaginal Diseases (Phase 4)
Xerostomia (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue